News
FTC investigators documented how pharmacy benefit managers imposed eye-popping markups on generic drugs used to treat deadly ...
The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...
1d
OptumRx, a pharmacy benefit manager accused in hundreds of lawsuits of contributing to the opioid crisis, sued five Kentucky ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback